Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Tas is a South Korean biotechnology company specializing in the development of microfluidic-based molecular diagnostic systems. The company focuses on Lab-on-a-Chip technology to enable rapid and precise DNA/RNA extraction and amplification for point-of-care testing (POCT). Their product portfolio includes automated molecular diagnostic devices and specialized microfluidic chips designed for detecting infectious diseases. By integrating complex laboratory processes into a single chip, Bio-Tas aims to provide accessible and efficient diagnostic solutions for clinical and research settings. The company's technology is particularly focused on miniaturizing traditional laboratory workflows into portable, high-performance formats.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioTas.